DVAX
Dynavax Technologies Corp
Price:  
12.99 
USD
Volume:  
1,226,857.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DVAX Relative Valuation

-51.6%
Upside

As of 2024-12-14, the Relative Valuation of Dynavax Technologies Corp (DVAX) is 6.28 USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.99 USD, the upside of Dynavax Technologies Corp based on Relative Valuation is -51.6%.

The range of the Relative Valuation is 3.91 - 8.54 USD.

Range Selected
Trailing P/E multiples 39.8x - 54.8x 47.3x
Forward P/E multiples 25.1x - 41.6x 33.4x
Fair Price 3.91 - 8.54 6.28
Upside -69.9% - -34.3% -51.6%
12.99 USD
Stock Price
6.28 USD
Fair Price

DVAX Relative Valuation - Historical P/E Data

Date P/E
2024-12-12 83.38
2024-12-11 82.87
2024-12-10 82.49
2024-12-09 82.42
2024-12-06 82.49
2024-12-05 82.36
2024-12-04 82.74
2024-12-03 82.10
2024-12-02 83.70
2024-11-29 82.55
2024-11-27 82.87
2024-11-26 81.27
2024-11-25 80.17
2024-11-22 79.73
2024-11-21 79.34
2024-11-20 78.12
2024-11-19 77.09
2024-11-18 75.04
2024-11-15 78.38
2024-11-14 85.95
2024-11-13 86.79
2024-11-12 86.66
2024-11-11 87.68
2024-11-08 83.51
2024-11-07 77.16
2024-11-06 78.89
2024-11-05 77.09
2024-11-04 75.68
2024-11-01 75.62
2024-10-31 76.07
2024-10-30 77.41
2024-10-29 75.81
2024-10-28 73.11
2024-10-25 68.75
2024-10-24 69.13
2024-10-23 69.78
2024-10-22 70.55
2024-10-21 70.48
2024-10-18 70.29
2024-10-17 70.10
2024-10-16 70.80
2024-10-15 69.07
2024-10-14 67.14
2024-10-11 66.95
2024-10-10 65.99
2024-10-09 67.98
2024-10-08 68.23
2024-10-07 69.13
2024-10-04 70.74
2024-10-03 71.83